The leaders of two key Senate health committees are trying to strike a deal on a group of drug-pricing bills, including ones to spur generic drug approvals, cut fees from pharmaceutical middlemen, and cap the cost of ins ...

In mid-April, the Centers for Disease Control (CDC) announced that people 65 or older with one Pfizer or Moderna updated booster can roll up their sleeves again if it has been at least four months since that last shot. ...

22 TSCL Form 990 - PD ...

As people in the United States struggle to access affordable insulin, the big three drug corporations that manufacture insulin have repeatedly and sharply raised prices and aggressively sought to extend lucrative product ...

The Senate Committee on Commerce, Science, and Transportation has recently passed the bipartisan Pharmacy Benefit Manager Transparency Act to increase transparency in prescription drug pricing and hold pharmacy benefit m ...

In our February update, we told you that according to federal audits, eight of the ten biggest Medicare Advantage insurers — representing more than two-thirds of the market — have deliberately overcharged Medicare for th ...

Each year the Social Security and Medicare Boards of Trustees release a report about the financial health of both Medicare and Social Security.  The good news is that Medicare’s hospital insurance trust fund, which helps ...